XML 26 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2014
Sep. 24, 2013
Cash flows from operating activities:    
Net income including noncontrolling interests $ 71,355 $ 65,928
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 43,682 36,864
Deferred income taxes (4,311) (1,739)
Loss on disposition of assets 3,461 2,641
Impairment and closure costs   84
Equity income from investments in unconsolidated affiliates (975) (571)
Distributions of income received from investments in unconsolidated affiliates 424 343
Provision for doubtful accounts 9 85
Share-based compensation expense 10,937 10,583
Changes in operating working capital:    
Receivables 9,924 4,813
Inventories (39) (53)
Prepaid expenses 2,150 583
Other assets (891) (3,201)
Accounts payable (3,499) (324)
Deferred revenue-gift cards (30,013) (27,670)
Accrued wages 1,554 1,319
Excess tax benefits from share-based compensation (2,236) (3,013)
Prepaid income taxes and income taxes payable 7,114 4,943
Accrued taxes and licenses 450 1,850
Other accrued liabilities 3,781 1,225
Deferred rent 2,361 2,536
Other liabilities 1,078 1,458
Net cash provided by operating activities 116,316 98,684
Cash flows from investing activities:    
Capital expenditures-property and equipment (89,645) (70,911)
Proceeds from sale of property and equipment, including insurance proceeds, and other 1,197 (39)
Net cash used in investing activities (88,448) (70,950)
Cash flows from financing activities:    
Repurchase of shares of common stock (39,966)  
Distributions to noncontrolling interests (3,064) (2,459)
Excess tax benefits from share-based compensation 2,236 3,013
Proceeds from noncontrolling interest contributions and other 487  
Proceeds from stock option and other deposits, net 607 23
Indirect repurchase of shares for minimum tax withholdings (5,638) (5,477)
Principal payments on long-term debt and capital lease obligations (380) (298)
Proceeds from exercise of stock options 3,206 13,001
Dividends paid to shareholders (20,923) (29,939)
Net cash used in financing activities (63,435) (22,136)
Net increase (decrease) in cash and cash equivalents (35,567) 5,598
Cash and cash equivalents-beginning of year 94,874 81,746
Cash and cash equivalents-end of year 59,307 87,344
Supplemental disclosures of cash flow information:    
Interest paid, net of amounts capitalized 1,774 1,803
Income taxes paid 28,659 23,410
Capital expenditures included in accounts payable 4,090 2,043
Receivable from noncontrolling in joint venture $ 243